The company’s portfolio generated over $1.5 billion in revenue last year. Despite this month’s retreat, the Nasdaq 100 is up 24% for the year, compared with a gain of less than 1% for the S&P 500.Many of those funds “are letting it ride,” Wilson wrote. -Great work/life balance with unlimited PTO Not proving with equipment to work (computer/laptop) despite the promise in the beginning.- Start-ups are fun and exciting! Cheeses and cured meats are imported from the Apulia region of Italy just like wines and beer, some of these products you can purchase to bring home. The company also reported positive results from non-human primate animal challenge studies.INO-4800 has been evaluated in a Phase 1/2a study in South Korea since June.Inovio has a September start timeline for a Phase 2/3 efficacy study in the U.S.A study protocol is being developed to assess efficacy in high-risk population, according to the company. - Pay for your own parking downtown Will there be a national policy? “We’ll see,” he said. (Bloomberg) -- The tech-led selloff in U.S. equities is likely only halfway done, according to the Morgan Stanley strategist whose warning last month about the top-heavy market now appears prescient.Down 13% from its Sept. 2 high, the Nasdaq 100 has tumbled below its 50-day average and is underperforming the S&P 500 for the first time in a year. That last number – the company’s FYQ2 revenue – is up an impressive 41% year-over-year.In another impressive display of Smartsheet’s strength, the company announced last month that it is acquiring the digital asset management company Brandfolder, in a deal worth $155. Folkes said, “The company continues to believe in the future of Triferic, dialysate and IV formulations, and is executing on its commercial strategy, which takes time to get adoption.” Speaking to this commercial strategy, RMTI is offering three-month evaluation periods for Triferic and has converted 75% of clinics who completed the evaluation period. Nice office, enabling real-time interaction, which is very positive, especially for the newbies! Where Western brands have traditionally used the star power of a single celebrity (think Kim Kardashian and Jessica Alba), many companies in China use armies of social-media influencers to sell products via e-commerce platforms to great effect.“I’d be very surprised if we don’t end up doing some kind of social commerce deal just because we’re becoming better and better at figuring out the risk-reward there,” he said. -Located just a couple blocks from Little Italy / Downtown SD CODI has significant levels of dry powder to take advantage of recent market dislocation… we like CODI's unique structure as a publicly-traded PE shop with permanent capital that affords the company enhanced investment flexibility/patience and competitive advantages,” Joseph opined.Accordingly, Joseph rates CODI a Buy along with a $22 price target. However, the Mercato delivery timeline from the date I ordered to yesterday’s delivery was rather spaced out. The current quarterly payout is 36 cents per common share, annualized to $1.44.The company funds the dividend with strong revenues and earnings. *Fun people (To watch Carr’s track record, click here)Overall, Moderna has robust backing amongst the Needham analyst’s colleagues, too. He notes several important points that underlie the company’s fundamental strength: “Twilio now has 8M registered developers… Cumulatively, it has now reached 3 trillion emails processed… Twilio has made more progress in making its entire portfolio available for healthcare use cases now that Studio and Functions are HIPAA-compliant.”At the bottom line, Kidron says simply, “We're increasingly confident in Twilio's ability to make platform investments, engage with developers, and expand its lead over competitors during the crisis. Following a three-week losing streak, the longest in about a year, all eyes are on the market. allow dogs in the office.Upper management is not aware of a lot that is happening in the company and blaming that on others. Q2 earnings were down 22% sequentially, but were inline with the analyst consensus.The company has used its earnings and liquidity to maintain its dividend. - Good work/life balance Top Analyst Offers 3 Stocks to Buy,2.4% FIXED Mortgage Refi, No Hidden Fees/Points,What Investors With $3.4 Trillion Are Buying During Covid,Will the Stock Market Crash Again? This is Addis! After attending last week’s virtual R&D day, the analyst is encouraged by the progress across the company's clinical programs. - Awesome location in Little Italy (Downtown Works Building) That level, which sits near 9,528, would be a 12% drop from current levels and a 23% decline from its all-time high of 12,421 reached earlier this month.“This is what happens when stocks get so extended -- corrections can be much bigger when remaining in an uptrend,” Wilson wrote in a note to clients.The Nasdaq 100 extended a three-week rout, falling as much as 2.4% as of 1:40 p.m. in New York. The stock’s share price is $16.91, and the $21 average price target suggests room for 24.5% upside growth in the next 12 months. The shares have an average price target of $23.33, suggesting a 43% upside from the current share price of $16.28. Using the platform, we got the full scoop, to find out why both are so compelling even with the risk involved.Rockwell Medical (RMTI)With the goal of transforming iron deficiency and anemia management in a wide variety of therapeutic areas, Rockwell Medical works to improve the lives of patients all over the world. Twilio’s platform makes it possible for customers to place or receive phone calls, chats, text messages, and even video conversations via connected devices, and built-in security systems keep it safe through user verification.The sudden move toward remote work and virtual offices in 1H20, precipitated by the coronavirus crisis, would seem on its face to be a boon for a company like Twilio – and the data bears that out. New Relic’s products permit software analytics, allowing the customer to use a cloud system to track app performance in order to perfect the software.